Sakar Healthcare shareholders and shareholding pattern
NSE: SAKARPharmaceuticals & BiotechnologySmall Cap
Last close ₹889.80down ₹62.00 (6.51%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹951.80.
52-week range of traded prices to 23 Oct 2026
₹352.00Low, 27 Oct 2025₹1,229.85High, 23 Sep 2026
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 23 Oct 2026 to consider: financial results and other business matters.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,980 Cr1,357th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 23 Oct 2026
- 46.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 23 Oct 2026
- 5.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 23 Oct 2026
- 13.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 23 Oct 2026
- 16.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. The filing of 23 Oct 2026
- 0.13
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 7,47,09017.5% delivered
Who owns Sakar Healthcare, filing by filing
Per cent of the company's shares. Every filing on record, from Sep 2021; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters51.70%
- Foreign institutions12.34%
- Indian institutions11.92%
- Individuals and others24.04%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Sep 2021Filed 9 Oct | Dec 2021Filed 6 Jan | Mar 2022Filed 6 Apr | Jun 2022Filed 8 Jul | Sep 2022Filed 14 Oct | Dec 2022Filed 10 Jan | Mar 2023Filed 12 Apr | Jun 2023Filed 7 Jul | Sep 2023Filed 18 Oct | Dec 2023Filed 17 Jan | Mar 2024Filed 20 Apr | Jun 2024Filed 17 Jul | Sep 2024Filed 19 Oct | Dec 2024Filed 16 Jan | Mar 2025Filed 16 Apr | Jun 2025Filed 16 Jul | Sep 2025Filed 18 Oct | Dec 2025Filed 20 Jan | Mar 2026Filed 17 Apr | Jun 2026Filed 17 Jul | Sep 2026Filed 12 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67.54% | 67.54% | 67.54% | 67.54% | 62.10% | 62.10% | 60.72% | 60.72% | 54.15% | 53.15% | 53.15% | 53.15% | 53.15% | 53.58% | 53.58% | 52.86% | 52.86% | 52.86% | 52.86% | 52.52% | 51.70% | |
| Indian promoters | 67.54% | 67.54% | 67.54% | 67.54% | 62.10% | 62.10% | 60.72% | 60.72% | 54.15% | 53.15% | 53.15% | 53.15% | 53.15% | 53.58% | 53.58% | 52.86% | 52.86% | 52.86% | 52.86% | 52.52% | 51.70% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 32.46% | 32.46% | 32.46% | 32.46% | 37.90% | 37.90% | 39.28% | 39.28% | 45.85% | 46.85% | 46.85% | 46.85% | 46.85% | 46.42% | 46.42% | 47.14% | 47.14% | 47.14% | 47.14% | 47.48% | 48.30% |
| Shares in issue | 1,71,18,000 | 1,71,18,000 | 1,71,18,000 | 1,71,18,000 | 1,86,18,000 | 1,86,18,000 | 1,90,40,000 | 1,90,40,000 | 2,13,49,910 | 2,17,49,910 | 2,17,49,910 | 2,17,49,910 | 2,17,49,910 | 2,19,49,910 | 2,19,49,910 | 2,22,49,910 | 2,22,49,910 | 2,22,49,910 | 2,22,49,910 | 2,22,49,910 | 2,22,49,910 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 1,14,08,543 | 21,57,000 | 21,57,000 | 6,57,000 | 21,57,000 | 21,57,000 | 10,79,500 | 10,79,500 | 29,66,910 | 1,39,45,953 | 1,39,45,953 | 4,00,000 | 0 | 2,00,000 | 2,00,000 | 5,00,000 | 5,00,000 | 5,00,000 | 2,00,000 | 2,00,000 | – |
| Promoters' shares locked in | 99,08,543 | 6,57,000 | 6,57,000 | 6,57,000 | 6,57,000 | 6,57,000 | 6,57,000 | 6,57,000 | 6,57,000 | 1,12,16,043 | 1,12,16,043 | 0 | 0 | 2,00,000 | 2,00,000 | 2,00,000 | 2,00,000 | 2,00,000 | 2,00,000 | 2,00,000 | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Sakar Healthcare promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Sanjay S Shah, 44.98%.Promoter buying and selling
| Holder | ||
|---|---|---|
| Sanjay S ShahIndividuals and Hindu undivided families | 44.98% | 1,00,08,543 |
| Shah AarshIndividuals and Hindu undivided families | 5.60% | 12,46,375 |
| Ritaben ShahIndividuals and Hindu undivided families | 1.10% | 2,45,000 |
| Shah AyushiIndividuals and Hindu undivided families | 0.02% | 4,000 |
No promoter shares are reported as pledged.
Largest public holders of Sakar Healthcare, filing by filing
Per cent, on the same shares as the split above.
| Holder | Sep 2021Filed 9 Oct | Dec 2021Filed 6 Jan | Mar 2022Filed 6 Apr | Jun 2022Filed 8 Jul | Sep 2022Filed 14 Oct | Dec 2022Filed 10 Jan | Mar 2023Filed 12 Apr | Jun 2023Filed 7 Jul | Sep 2023Filed 18 Oct | Dec 2023Filed 17 Jan | Mar 2024Filed 20 Apr | Jun 2024Filed 17 Jul | Sep 2024Filed 19 Oct | Dec 2024Filed 16 Jan | Mar 2025Filed 16 Apr | Jun 2025Filed 16 Jul | Sep 2025Filed 18 Oct | Dec 2025Filed 20 Jan | Mar 2026Filed 17 Apr | Jun 2026Filed 17 Jul | Sep 2026Filed 12 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tata Capital Healthcare Fund IIAlternative investment funds | – | – | – | – | – | – | – | – | 10.82% | 10.62% | 10.62% | 10.62% | 10.62% | 10.52% | 10.52% | 10.38% | 10.38% | 10.38% | 10.38% | 10.38% | 10.38% |
| Hbm Healthcare Investments (Cayman) LtdForeign portfolio investors, category II | – | – | – | – | 8.06% | 8.06% | 7.88% | 7.88% | 7.03% | 6.90% | 6.90% | 6.90% | 6.90% | 6.83% | 6.83% | 6.74% | 6.74% | 6.74% | 6.74% | 6.74% | 6.74% |
| Cobra India (Mauritius) LimitedForeign portfolio investors, category II | 8.76% | 8.76% | 8.76% | 8.76% | 8.06% | 8.06% | 7.86% | 7.86% | 7.01% | 6.86% | 6.62% | 6.62% | 6.52% | 6.46% | 6.46% | 6.38% | 6.28% | 6.17% | 5.89% | 3.94% | 3.49% |
| Hi-Tech Chemicals LimitedCompanies | – | – | – | – | – | – | – | – | – | 1.84% | 1.84% | 1.91% | 1.96% | 1.96% | 1.96% | 2.83% | 2.82% | 2.45% | 1.06% | – | – |
| Subhash Phootarmal RathodResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | 2.79% | 2.66% | 2.61% | 2.53% | 2.66% | 2.39% | – | – | – | – | – | – | – | – |
| Subhash RathodResident individuals, over ₹2 lakh at face value | 2.55% | 2.55% | 2.00% | 2.41% | 2.32% | 2.88% | 2.79% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| AYAN SHIRISHBHAI SHAHResident individuals, over ₹2 lakh at face value | 1.45% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.